CDKN1A and metabolic dysfunction-associated steatotic liver disease: Therefore, the rs762623 in cyclin dependent kinase inhibitor 1A (CDKI1A) which encodes the cellular senescence marker p21, was significantly associated with the development of progressive liver disease in two cohorts of biopsy-proven NAFLD from UK (n = 323) and Finland (n = 123) [67].